Dermata Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
DRMA Key Statistics
Stock Snapshot
As of today, Dermata Therapeutics(DRMA) shares are valued at $1.87. The company's market cap stands at 1.92M, with a P/E ratio of -0.09.
As of 2025-12-27, Dermata Therapeutics(DRMA) stock has fluctuated between $1.80 and $2.46. The current price stands at $1.87, placing the stock +4.2% above today's low and -23.8% off the high.
Dermata Therapeutics(DRMA) shares are trading with a volume of 684.26K, against a daily average of 2.21M.
During the past year, Dermata Therapeutics(DRMA) stock moved between $1.80 at its lowest and $23.70 at its peak.
During the past year, Dermata Therapeutics(DRMA) stock moved between $1.80 at its lowest and $23.70 at its peak.
DRMA News
(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggr...
